首页> 外文期刊>The Journal of Allergy and Clinical Immunology >Association of thromboxane A1 synthase (TBXAS1) gene polymorphism with acute urticaria induced by nonsteroidal anti-inflammatory drugs
【24h】

Association of thromboxane A1 synthase (TBXAS1) gene polymorphism with acute urticaria induced by nonsteroidal anti-inflammatory drugs

机译:非甾体类抗炎药引起的血栓烷A1合酶(TBXAS1)基因多态性与急性荨麻疹的相关性

获取原文
获取原文并翻译 | 示例
           

摘要

Nonsteroidal anti-inflammatory drugs (NSAIDs) are among the most commonly prescribed drugs all over the world and represent the second most frequent cause of drug-induced hypersensitivity reactions (0.5% to 1.9% of the general population). In some circumstances an underlying disease, such as chronic urticaria or bronchial asthma, accompanies the clinical expression of this hypersensitivity. According to the pattern of reactivity among different NSAIDs, these reactions can be classified into cross-reactive or multiple hypersensitivity (MR), with cross-reactivity among different nonstructurally related NSAIDs, and selective (SR), in which a unique specific NSAID is the culprit drug.
机译:非甾体类抗炎药(NSAIDs)是世界上最常用的处方药之一,代表了由药物引起的超敏反应的第二常见原因(占总人口的0.5%至1.9%)。在某些情况下,潜在的疾病,例如慢性荨麻疹或支气管哮喘,伴随着这种超敏反应的临床表现。根据不同NSAID之间的反应模式,这些反应可分为交叉反应或多重超敏反应(MR),在不同的非结构相关NSAID之间具有交叉反应,以及选择性(SR),其中唯一的特定NSAID是罪魁祸首。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号